Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Feb;41(2):187-91.
doi: 10.1038/ng.309. Epub 2009 Jan 18.

A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia

Affiliations

A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia

Perundurai S Dhandapany et al. Nat Genet. 2009 Feb.

Abstract

Heart failure is a leading cause of mortality in South Asians. However, its genetic etiology remains largely unknown. Cardiomyopathies due to sarcomeric mutations are a major monogenic cause for heart failure (MIM600958). Here, we describe a deletion of 25 bp in the gene encoding cardiac myosin binding protein C (MYBPC3) that is associated with heritable cardiomyopathies and an increased risk of heart failure in Indian populations (initial study OR = 5.3 (95% CI = 2.3-13), P = 2 x 10(-6); replication study OR = 8.59 (3.19-25.05), P = 3 x 10(-8); combined OR = 6.99 (3.68-13.57), P = 4 x 10(-11)) and that disrupts cardiomyocyte structure in vitro. Its prevalence was found to be high (approximately 4%) in populations of Indian subcontinental ancestry. The finding of a common risk factor implicated in South Asian subjects with cardiomyopathy will help in identifying and counseling individuals predisposed to cardiac diseases in this region.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Morphology and histopathology of heart, and cardiac transcript analysis of individuals with the 25-bp deletion. (a) Morphology of the heart of a subject with DCM. The subject was a child homozygous for the deletion. Note the marked dilation of the left and right ventricles. (b) Histopathological section of the same subject showing hypertrophied myofibers separated from each other by increased connective tissue (hematoxylin and eosin, × 400). (c) Transverse section through both ventricles of a 40-y-old man homozygous for the deletion showing marked asymmetric hypertrophy involving septum (IVS). (d) Histopathological section of the septal myocardium of the same individual showing ‘swirling’ of hypertrophied myofibers amid connective tissue disarray (hematoxylin and eosin, × 400). (e) Characterization of cardiac transcripts. The mRNA from the endomyocardial biopsies of an affected subject heterozygous for the 25-bp deletion was reverse transcribed, amplified, subcloned and sequenced. The sequence shows a normal transcript and a mutant transcript with absence of exon 33. AO, aorta; RA, right atrium; PA, pulmonary artery; RV, right ventricle; LV, left ventricle; TV, tricuspid valve; IVS, intraventricular septum; MV, mitral valve; AV, aortic valve.
Figure 2
Figure 2
Expression and localization of cMyBP-CWT and cMyBP-CΔEx33 proteins in neonatal rat cardiomyocytes. Recombinant adenoviruses that expressed mouse cMyBP-CWT (WT) or cMyBP-CΔEx33 (mutant) were introduced into rat neonatal cardiomyocytes. Noninfected cardiomyocytes were used as control. (a,b) Three days after infection, cardiomyocytes were fixed and immunostained with either cMyBP-C antibodies (green) (a) raised against the C0-C1 domain carried by native, WT and mutant proteins or myc-tag antibodies carried only by the WT and mutant proteins (green) (Roche) (b) and costained with α-tropomyosin (red) (Sigma). (c,d) Representative protein blots obtained by using cMyBP-C (c) and Myc (d) antibodies in control and WT- and mutant-infected neonatal rat cardiomyocytes. Twenty μg of total cardiomyocytes lysates was separated on a 4–15% linear gradient SDS-PAGE, transferred to nitrocellulose membrane, and immunoblotted as described in Supplementary Methods. In lysates from noninfected neonatal cardiomyocytes and WT-infected cells, the cMyBP-C antibody detected a major band of the expected molecular weight of 144 kDa and overexpression of mutant cMyBP-C showed the predicated truncated protein of approximately 140 kDa. α-TM was used as a load control.
Figure 3
Figure 3
Global distribution of MYBPC3 deletion in indigenous populations. For populations with the MYBPC3 deletion, the frequency of the deletion-containing allele is shown. See Supplementary Table 5 for details of the populations studied.

Similar articles

Cited by

References

    1. Reddy KS, Shah B, Varghese C, Ramadoss A. Responding to the threat of chronic diseases in India. Lancet. 2005;366:1744–1749. - PubMed
    1. Joshi P, et al. Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. J. Am. Med. Assoc. 2007;297:286–294. - PubMed
    1. Liew CC, Dzau VJ. Molecular genetics and genomics of heart failure. Nat. Rev. Genet. 2004;5:811–825. - PubMed
    1. Flavigny J, et al. Biomolecular interactions between human recombinant h-MyHC and cMyBP-Cs implicated in familial hypertrophic cardiomyopathy. Cardiovasc. Res. 2003;60:388–396. - PubMed
    1. Flavigny J, et al. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes. J. Mol. Biol. 1999;294:443–456. - PubMed

Publication types